In Vitro and Clinical Compassionate Use Experiences with the Drug-Repurposing Approach CUSP9v3 in Glioblastoma

Halatsch, M.-E., Dwucet, A., Schmidt, C. J., Mühlnickel, J., Heiland, T., Zeiler, K., Siegelin, M. D., Kast, R. E., & Karpel-Massler, G. (2021). In Vitro and Clinical Compassionate Use Experiences with the Drug-Repurposing Approach CUSP9v3 in Glioblastoma. Pharmaceuticals, 14(12), 1241. https://doi.org/10.3390/ph14121241
Authors:
Marc-Eric Halatsch
Annika Dwucet
Carl Julius Schmidt
Julius Mühlnickel
Tim Heiland
Katharina Zeiler
Markus D Siegelin
Richard Eric Kast
Georg Karpel-Massler
Affiliated Authors:
Markus D Siegelin
Author Keywords:
cusp9*
cusp9v3
glioblastoma
drug repurposing
compassionate use
Publication Type:
Article
Unique ID:
10.3390/ph14121241
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: